Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS
· Delayed Price · Currency is USD
1.240
+1.200 (3,000.00%)
Mar 7, 2025, 4:00 PM EDT
Hemogenyx Pharmaceuticals Employees
Hemogenyx Pharmaceuticals had 17 employees as of December 31, 2023. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
n/a
Profits / Employee
-$385,264
Market Cap
9.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Hemogenyx Pharmaceuticals News
- 1 day ago - Hemogenyx Pharmaceuticals reports FY results - Seeking Alpha
- 26 days ago - Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report - Accesswire
- 5 weeks ago - Hemogenyx Pharmaceuticals PLC Announces First Patient Safety - Accesswire
- 6 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials - Accesswire
- 7 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Institutional Investment - Accesswire
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1 - Accesswire
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes - Accesswire
- 3 months ago - Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000 - Accesswire